Image source: The Motley Fool.DATETuesday, April 28, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — John WrenExecutive…
Bad Marienberg (www.aktiencheck.de) - DAX Analyse: Merck, Commerzbank und RWE glänzen – warum Qiagen,Bayer und Öl-Angst den DAX unter 24.100…
By John Vandermosten, CFANASDAQ: ACHVAchieve Life Sciences, Inc. (NASDAQ: ACHV) generated significant news flow in April, announcing the arrival of…
Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Guggenheim reiterates Buy on Merck stock ahead of earnings…
Merck heads into Q1 with strong Keytruda demand but rising pressure from generics, vaccines slump, and deal costs persist. Can…
In the latest trading session, Merck (MRK) closed at $111.9, marking a -2.37% move from the previous day.…
FDA grants priority review to Mercks sBLAs for Keytruda & Keytruda SC in combination with Pfizers Padcev in cisplatin-eligible MIBC…
Merck stock up 11% YTD as Keytruda growth, pipeline gains and M&A lift outlook, but patent risks, Gardasil slump and…
In the closing of the recent trading day, Merck (MRK) stood at $117.1, denoting a -1.65% move from the preceding…
UBS reiterates Merck stock rating on pipeline strength…
Both are great stocks to buy in the current environment, but which one is the better bet?…
Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…
The FDA grants priority review to Merck and Daiichis BLA for ifinatamab deruxtecan to treat extensive-stage small cell lung cancer.…
In the latest trading session, Merck (MRK) closed at $120.15, marking a -1.05% move from the previous day.…
Wien (www.aktiencheck.de) - Merck-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), rät in einer…
Daniel Goldstein hat festgestellt, dass das Krebsmedikament Keytruda in zu hohen Dosen verabreicht wird. Der Hersteller verdient damit Milliarden –…
The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big…
Though both dominate oncology, a stronger growth outlook and clearer targets may give AstraZeneca an edge over Merck.…
Image source: The Motley Fool.DateTuesday, Nov. 4, 2025 at 8:30 a.m. ETCall participantsChief Executive Officer — Kristin PeckChief Financial Officer…
Image source: The Motley Fool.DATETuesday, May 6, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Kristin PeckChief Financial Officer…
The latest trading day saw Merck (MRK) settling at $119.28, representing a -1.3% change from its previous close.…
Merck (MRK) concluded the recent trading session at $120.29, signifying a +1.85% move from its prior days close.…
Merck (MRK) reached $118.1 at the closing of the latest trading day, reflecting a -1.28% change compared to its last…
…
MRK stock has surged over 50% in six months, but looming patent risks and weak vaccine sales raise questions on…
Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock…
Bad Marienberg (www.aktiencheck.de) - Dow Jones Analyse: Friedenshoffnung treibt Dow Jones höher. Sherwin-Williams, Merck Amazon führen den Befreiungsschlag anDow…
RAHWAY/FOSTER CITY (dpa-AFX) - Der US-Pharmakonzern Merck & Co will auf seiner Einkaufstour das Biotechunternehmen…
…
Merck übernimmt das HBM-Portfoliounternehmen Terns Pharmaceuticals für USD 6.7 Milliarden^HBM Healthcare Investments AG / Schlagwort(e): Ankauf/PartnerschaftMerck übernimmt das HBM-Portfoliounternehmen Terns…
Der US-Pharmakonzern will Terns für 6,7 Milliarden Dollar übernehmen. Damit sichert sich Merck & Co das Blutkrebsmedikament des Biotechunternehmens.…
RAHWAY/FOSTER CITY (dpa-AFX) - Merck & Co setzt seine Einkaufstour fort und will das Biotechunternehmen…
Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.…
Merck & Co Inc (NYSE:MRK, XETRA:6MK) announced on Wednesday that it will acquire US biotech firm Terns Pharmaceuticals (NASDAQ:TERN) for…
RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co befindet sich Kreisen zufolge in fortgeschrittenen Verhandlungen…
Merck is nearing a roughly $6 billion all-cash ?deal to buy biotech firm Terns Pharma , the Financial Times reported…
Merck (MRK) reached $115.68 at the closing of the latest trading day, reflecting a +1.31% change compared to its last…
Merck (MRK) closed at $114.5 in the latest trading session, marking a -1.18% move from the prior day.…
Todays Research Daily features new research reports on 16 major stocks, including Merck Co., Inc. (MRK), TotalEnergies SE (TTE)…
J&J edges past MRK with stronger growth outlook, rising estimates and diversified business, positioning it as the clearer pharma pick…
Bad Marienberg (www.aktiencheck.de)???? Merck im defensiven Höhenflug? HSBC senkt Kursziel auf 135 EUR - Aktienanalyse bleibt klar auf "buy"Die Aktie…
MRK bets on new products and a growing pipeline as Keytruda nears 2028 LOE, with $70B potential commercial opportunities projected…
Bad Marienberg (www.aktiencheck.de)???? Merck & Co. im Aufwind: Wells Fargo hebt Kursziel auf 150 USD - Neue Hoffnungsträger in der…
Image source: The Motley Fool.DateWednesday, Mar. 11, 2026 at 4:30 p.m. ETCall participantsChief Executive Officer — Alison MooreChief Financial Officer…
The latest trading day saw Merck (MRK) settling at $117.11, representing a +1.14% change from its previous close.…
Merck KGaA stock overview after recent performance Merck KGaA (XTRA:MRK) has drawn fresh attention after a period of weaker share…
Pharmaceutical stocks like Eli Lilly and Merck are good places to help investors ride out a recent rise in geopolitical…
FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Merck KGaA bei einem fairen Aktienwert von 150 Euro…